stockportfolio.pro
Stocks / PEN vs SNN
PEN vs SNN
Penumbra, Inc. and Smith & Nephew plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Penumbra, Inc. (PEN) | Smith & Nephew plc (SNN) | |
|---|---|---|
| Market cap | $12.6B | $12.9B |
| Revenue (latest FY) | $1.40B | $6.16B |
| Net income (latest FY) | $177.69M | $625.00M |
| Revenue growth (5y CAGR) | 20.2% | 5.7% |
| Net margin | 12.7% | 10.1% |
| Return on equity | 12.4% | 11.8% |
| P/E ratio | 73.8 | 21.3 |
| Dividend yield | — | 2.5% |
| Profitable years (of last 10) | 8 | 4 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open PEN — free Open SNN — freeFrequently asked questions
Which is bigger, PEN or SNN?
Smith & Nephew plc is larger by market capitalization — $12.9B versus $12.6B.
Which grows faster, PEN or SNN?
Over the last five fiscal years, Penumbra, Inc. grew revenue faster — 20.2%/yr versus 5.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.